CapTemY90 for Grade 2/3 NET Liver Metastases
Clinical trial NCT04339036 · RECRUITING
Trial details
- NCT number
- NCT04339036
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2028-07-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.